152 related articles for article (PubMed ID: 8950992)
1. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.
Eliopoulos AG; Dawson CW; Mosialos G; Floettmann JE; Rowe M; Armitage RJ; Dawson J; Zapata JM; Kerr DJ; Wakelam MJ; Reed JC; Kieff E; Young LS
Oncogene; 1996 Nov; 13(10):2243-54. PubMed ID: 8950992
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
3. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions.
Floettmann JE; Eliopoulos AG; Jones M; Young LS; Rowe M
Oncogene; 1998 Nov; 17(18):2383-92. PubMed ID: 9811470
[TBL] [Abstract][Full Text] [Related]
5. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
Eliopoulos AG; Young LS
Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
[TBL] [Abstract][Full Text] [Related]
6. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
7. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
8. TRAF interactions with raft-like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1.
Ardila-Osorio H; Pioche-Durieu C; Puvion-Dutilleul F; Clausse B; Wiels J; Miller W; Raab-Traub N; Busson P
Int J Cancer; 2005 Jan; 113(2):267-75. PubMed ID: 15386359
[TBL] [Abstract][Full Text] [Related]
9. Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1.
Henriquez NV; Floettmann E; Salmon M; Rowe M; Rickinson AB
J Immunol; 1999 Mar; 162(6):3298-307. PubMed ID: 10092782
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor necrosis factor-induced phenotypes by short intracellular versions of latent membrane protein-1.
Ndour PA; Ouk TS; Brocqueville G; Mougel A; Vanhecke E; Feuillard J; Coll J; Adriaenssens E
Cell Signal; 2010 Feb; 22(2):303-13. PubMed ID: 19796681
[TBL] [Abstract][Full Text] [Related]
11. The Epstein-Barr virus latent membrane protein 1 (LMP1) enhances TNF alpha-induced apoptosis of intestine 407 epithelial cells: the role of LMP1 C-terminal activation regions 1 and 2.
Kawanishi M
Virology; 2000 May; 270(2):258-66. PubMed ID: 10792984
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth.
Baxendale AJ; Dawson CW; Stewart SE; Mudaliar V; Reynolds G; Gordon J; Murray PG; Young LS; Eliopoulos AG
Oncogene; 2005 Nov; 24(53):7913-23. PubMed ID: 16091748
[TBL] [Abstract][Full Text] [Related]
13. A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activation.
Georgopoulos NT; Steele LP; Thomson MJ; Selby PJ; Southgate J; Trejdosiewicz LK
Cell Death Differ; 2006 Oct; 13(10):1789-801. PubMed ID: 16429118
[TBL] [Abstract][Full Text] [Related]
14. Constitutive CD40 signaling phenocopies the transforming function of the Epstein-Barr virus oncoprotein LMP1 in vitro.
Hatzivassiliou EG; Kieff E; Mosialos G
Leuk Res; 2007 Mar; 31(3):315-20. PubMed ID: 16919331
[TBL] [Abstract][Full Text] [Related]
15. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.
Hatzivassiliou E; Miller WE; Raab-Traub N; Kieff E; Mosialos G
J Immunol; 1998 Feb; 160(3):1116-21. PubMed ID: 9570524
[TBL] [Abstract][Full Text] [Related]
16. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
[TBL] [Abstract][Full Text] [Related]
17. TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.
Grammer AC; Swantek JL; McFarland RD; Miura Y; Geppert T; Lipsky PE
J Immunol; 1998 Aug; 161(3):1183-93. PubMed ID: 9686578
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus LMP1 modulates the malignant potential of gastric carcinoma cells involving apoptosis.
Sheu LF; Chen A; Wei YH; Ho KC; Cheng JY; Meng CL; Lee WH
Am J Pathol; 1998 Jan; 152(1):63-74. PubMed ID: 9422524
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y
Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
